newsfilter
← Latest News
GlobeNewswire·

Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

SAN DIEGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the pricing of an